AI in Healthcare and Clinical Responsibility: Why Governance Has Become Essential
Summary:
Artificial intelligence is already part of clinical practice, supporting diagnoses, identifying risks, and contributing to care-related decision-making. As these technologies take on a more active role in patient care, a growing need has emerged: establishing oversight, transparency, and accountability mechanisms that ensure their safe and responsible use.
In the fifth article of the series “AI in Healthcare: Credibility, Safety, and Impact on Clinical Practice,” we examine why AI governance must be integrated into clinical governance and how healthcare organizations can structure processes to evaluate, oversee, and monitor these tools throughout their entire lifecycle. The article addresses topics such as professional accountability, risk classification, transparency, traceability, and the strategic role of governance in healthcare’s digital transformation.
Key Topics Covered:
- The role of artificial intelligence in clinical practice
- Governance, oversight, and accountability in the use of AI
- AI as part of clinical governance
- Risk assessment, monitoring, and management
- Transparency, traceability, and trust
- The role of governance in healthcare digital transformation
Content:
Artificial intelligence (AI) is advancing rapidly across healthcare. Tools capable of supporting diagnoses, identifying risks, analysing medical images and contributing to clinical decision-making are already part of routine practice in many institutions around the world.
This transformation creates important opportunities to enhance the analytical capabilities of physicians and other healthcare professionals, anticipate risks, and support increasingly complex decisions. At the same time, it highlights the need to define responsibilities, establish oversight criteria and create mechanisms that ensure these tools are used safely, transparently and in accordance with the principles of clinical practice.
Across the globe, healthcare organizations, regulators and professional bodies are discussing how to incorporate AI responsibly into clinical care. Despite differences in regulatory approaches, a growing consensus has emerged: whenever AI influences decisions related to patient care, its adoption must be accompanied by clinical oversight, governance and clear accountability mechanisms.
This discussion marks an important shift. AI governance is no longer a topic confined to technology and innovation departments; it is becoming an integral component of clinical governance.
Artificial Intelligence Has Entered the Clinical Decision-Making Process
For decades, the adoption of new technologies in hospitals was largely confined to areas such as information technology, clinical engineering or innovation. This model worked well when these tools played primarily administrative, operational or indirect support roles.
Artificial intelligence changes that landscape. When an algorithm participates in risk identification, supports diagnosis, estimates prognosis or influences clinical decisions, it becomes part of the care process itself.
At that point, the discussion extends beyond technology to encompass quality of care, patient safety, professional responsibility and institutional oversight.
Across healthcare systems worldwide, there is growing recognition that clinicians’ autonomy must be preserved and that AI should serve as a decision-support tool, never as a substitute for the healthcare professional responsible for patient care. Rather than limiting innovation, this principle creates the conditions necessary for AI to be incorporated consistently and safely into clinical practice.
Clinical decision-making has always relied on integrating multiple sources of information. Medical history, physical examination, laboratory tests, imaging studies, clinical protocols and professional experience all contribute to this process. None of these elements determines a course of action on its own. Their value lies in their ability to improve understanding of the clinical situation and provide a stronger foundation for decision-making.
Artificial intelligence represents another layer of information available to healthcare professionals. Its contribution lies in its ability to process large volumes of data, identify complex patterns and generate real-time risk estimates. Responsibility for the final decision, however, remains with the professional who integrates these insights into the specific context of each patient.
From this perspective, AI should not be viewed as a replacement for clinical reasoning but as a tool that enhances the analytical capabilities of both healthcare professionals and organizations. Clinical judgment remains the element that transforms information into decisions, and decisions into care.
From Technology Governance to Clinical Responsibility
Over recent decades, hospitals have developed increasingly sophisticated structures to ensure quality and safety. Infection prevention and control, clinical protocols, medical record review, accreditation, risk management and patient safety have become routine components of institutions committed to excellence.
The arrival of artificial intelligence does not create an entirely new responsibility. It expands one that already exists.
If a tool participates in clinical decision-making, influences patient management or contributes to risk assessment, it should naturally be subject to the same oversight mechanisms applied to other aspects of clinical care.
For this reason, AI governance should be understood as an extension of clinical governance itself. The goal is not simply to regulate technologies used in healthcare but to ensure they are aligned with the quality, safety, transparency and accountability standards that already guide patient care.
This perspective is important because it prevents AI from being viewed merely as an innovation initiative or digital transformation project. Its true value lies not in the sophistication of its algorithms but in its ability to improve decisions and ultimately achieve better outcomes for patients and healthcare organizations.
A New Competency for Healthcare Organizations
As the number of AI applications used by hospitals and healthcare systems continues to grow, organizations must establish structured processes to evaluate, monitor and oversee these technologies throughout their lifecycle.
One of the first challenges is understanding which AI solutions are already present within the institution. In many cases, they are not limited to tools explicitly labelled as artificial intelligence. They may be embedded within clinical decision-support systems, imaging platforms, electronic health records or applications used directly by healthcare professionals.
For this reason, mapping existing solutions is often the first step in any governance programme. Once this inventory is established, applications can be classified according to their potential clinical impact. Tools that influence clinical decisions or may affect patient safety require greater oversight than those used solely for administrative or operational purposes.
As these initiatives evolve, organizations also need structures capable of evaluating evidence, monitoring outcomes, and supporting decisions related to the adoption of AI technologies. Consequently, many institutions are beginning to establish multidisciplinary committees dedicated to AI, bringing together representatives from clinical practice, quality, patient safety, technology, legal and management teams.
This evolution also expands the role of clinical and institutional leadership. Leaders are increasingly responsible for addressing essential questions: Which AI tools are currently being used? What evidence supports their adoption? How is their performance monitored? Have healthcare professionals received appropriate training?
These are essentially the same questions organizations already ask when evaluating clinical protocols, medications, medical devices or new technologies. The difference is that they now also apply to artificial intelligence.
It is precisely the combination of inventory, risk classification, institutional oversight and continuous monitoring that gives shape to the concept of AI clinical governance.
Transparency, Traceability, and Trust
Another central element of the global discussion surrounding AI in healthcare is transparency.
Healthcare professionals need to understand the role AI plays within clinical processes, its intended purpose, its limitations and how its recommendations should be interpreted.
Likewise, healthcare organizations must be able to monitor these tools over time, document processes, evaluate outcomes and maintain appropriate oversight mechanisms.
Trust in healthcare has never been built on technology alone. It is built on evidence, transparency, accountability and continuous learning.
For this reason, concepts such as traceability, explainability and human oversight have become central to discussions about the responsible adoption of AI in healthcare.
The Next Stage of Digital Transformation in Healthcare
For many years, digital transformation was primarily associated with digitizing processes, collecting data and generating performance indicators. Artificial intelligence marks the beginning of a new stage in that journey.
The challenge is no longer simply to record information. It is to transform information into knowledge, and knowledge into better decisions.
In this new landscape, governance plays a strategic role. It enables healthcare organizations to adopt emerging technologies while remaining aligned with their clinical values, quality standards and commitment to patient safety.
Across the world, discussions about AI in healthcare continue to evolve rapidly. Although regulatory frameworks differ between countries and healthcare systems, the underlying principle remains the same: integrating AI into healthcare requires clinical oversight, institutional accountability and active participation from healthcare professionals.
At Epimed, this vision has guided our work for many years. We believe that trustworthy artificial intelligence depends on four inseparable pillars: high-quality data, clinical validation, integration into clinical workflows and governance.
The first three pillars were explored in previous articles in this series. This article reinforces the importance of the fourth.
The true digital transformation of healthcare does not occur when institutions acquire algorithms. It occurs when they develop the capacity to govern them, integrate them into clinical practice and use them to strengthen what has always been at the heart of healthcare: patient care.
_________________________________________________________________________________________________
This is the fifth publication in the editorial series “AI in Healthcare: Credibility, Safety, and Impact on Clinical Practice,” produced by Epimed Solutions.
Author: Dr. Carlos Eduardo Reis, physician, entrepreneur, Co-founder and CEO of Epimed Solutions.
